Physician

Shanna Burris Meads, MD

According to 2025 Medicare claims, Shanna Meads, MD (NPI: 1023054624) practices dermatology in the Tyler, TX market, with the plurality of this provider's patient population coming from Smith, TX. This provider's primary affiliated billing organization is EPIPHANY DERMATOLOGY PA (NPI: 1043615263; TIN: 47-2190514) and primary practice location at 75703-0585.

Meads' data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 955 traditional Medicare patients, billed 5,304 HCPCS/CPT codes, and received $610,298 in Medicare payments. The top billing code was 17311 (Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, 1-5 tissue blocks). Part D data shows 838 prescription claims across 409 beneficiaries totaling $64,480 in drug costs, led by Fluorouracil (Fluorouracil). Open Payments data shows 7 records totaling $127. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $130,361 and ending at $64,480. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	1,446	8,083	$572,363
2016	1,358	7,271	$547,867
2017	1,413	7,916	$588,328
2018	1,421	7,725	$611,267
2019	1,473	8,785	$711,488
2020	1,258	6,859	$610,628
2021	1,124	5,344	$521,653
2022	963	4,787	$622,976
2023	987	5,390	$683,152
2024	955	5,304	$610,298

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	421	835	$130,361
2016	346	765	$98,752
2017	387	944	$78,226
2018	444	953	$112,556
2019	458	974	$195,577
2020	470	999	$217,924
2021	416	922	$134,661
2022	320	730	$190,711
2023	381	785	$81,472
2024	409	838	$64,480

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
17311	Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, 1-5 tissue blocks	387	486	$452
11102	Biopsy of related skin growth, first growth	366	459	$62
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	549	877	$62
17000	Destruction of precancer skin growth, 1 growth	309	453	$35
17003	Destruction of precancer skin growth, 2-14 growths	231	1,317	$5

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Fluorouracil	Fluorouracil	63	1,901	$4,467
Doxycycline Monohydrate	Doxycycline Monohydrate	198	3,036	$2,743
Fluocinonide	Fluocinonide	47	1,194	$1,472
Clobetasol Propionate	Clobetasol Propionate	30	1,000	$1,413
Metronidazole	Metronidazole	22	630	$984

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	7	$127	GENZYME CORPORATION
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Shanna Burris Meads, MD?

Tedicare shows public-source Medicare data for Shanna Burris Meads, MD (NPI 1023054624), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Shanna Burris Meads, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Shanna Burris Meads, MD?

Shanna Burris Meads, MD is linked to EPIPHANY DERMATOLOGY PA (billing NPI 1043615263) in the available physician profile data.

Does Shanna Burris Meads, MD have Open Payments data?

Shanna Burris Meads, MD has 7 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.